In summary, our study shows that loss of the GALNT6 enzyme occurs in a subset of early-stage colorectal cancer patients and is significantly associated with poor (G3) differentiation, right-sided location, lymphovascular invasion, MSI subtype, and shorter overall survival. This evidence concerns the gene GALNT6 and colorectal cancer.